Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road
dpa

HOME > dpa

German government takes stake in coronavirus vaccine developer Curevac

June 17, 2020


Abstract : In the global race for a coronavirus vaccine, the German government is joining forces with the German biotech company Curevac in order to protect it against a potential takeover from abroad.

Partly to achieve more economical independence, the German government invests in the biotech company Curevac. (picture alliance/dpa)

In the global race for a coronavirus vaccine, the German government is joining forces with the German biotech company Curevac in order to protect it against a potential takeover from abroad. Minister of Economics Peter Altmaier, a member of the center-right Christian Democrats (CDU), said on Monday that the state-owned development bank KfW will aquire approximately 23 percent of the shares of the company for 300 million euros. The aim of the move is to give financial security to the company of majority shareholder Dietmar Hopp. The state does not want to influence business decisions, Hopp said. The Tübingen-based company has been conducting research on a vaccine since January.

Altmaier said that the investment was also of great importance in terms of industrial policy. Important research results and technologies are needed in Germany and Europe. The background to this is also the goal of the German government to achieve greater independence in the production of active ingredients in medicines and vaccines. "With this investment we are taking a first step in this direction."

A race has emerged worldwide to see who can develop the first vaccine against the coronavirus. It is uncertain when one will be ready. Hopes were pinned on Curevac even before the coronavirus spread to Germany. At the end of January, the international vaccine partnership, the CEPI, granted the company a funding commitment of 8.3 million U.S. dollars (approximately 7.5 million euros).

Notice: No person, organization and/or company shall disseminate or broadcast the above article on Xinhua Silk Road website without prior permission by Xinhua Silk Road.

Scan the QR code and push it to your mobile phone

Keyword: German government investment anti-epidemic

Reading:

Commentary: China-Africa anti-epidemic efforts pave way for better world

China's economy to continue recovery in H2: analysts

China's foreign trade faces severe challenges in 2020: report

China's service sector picks up steam in May

China, Cambodia intergovernmental committee holds meeting via video

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial